Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford key to network of ultra-powerful MRI scanners

General Research

Researchers at Oxford University are playing a key role in expanding the UK's network of ultra-powerful MRI machines. Oxford and Nottingham Universities have been pioneering research using so-called 'Ultra-high field' (UHF) MRI scanners, which are at the cutting edge of biomedical imaging. They are now joined by new systems in Cardiff, Cambridge and Glasgow.

UHF MRI has the potential to provide unique insights into key medical conditions including dementia, cerebrovascular disease and mental health. Research is now focusing on taking the technology out of the lab and into hospital, with the UK poised to play a major role.

Using the standard measure of magnetic power, the Tesla, the machines are rated at 7 Tesla (7T). One Tesla is about 20,000 times the strength of Earth's magnetic field and medical MRI scanners are around 1.5 Tesla.

Read more

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

COVID-19: does exercising really reduce the risk?

Coronavirus COVID-19 General

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.